Micellar Nanocarriers: Pharmaceutical Perspectives

By Vladimir Torchilin. Pharmaceutical Research, 2006

1,794 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/eacbf51cb18f1af25d4e9ee54d3a248fe75a150b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

In Molecular Biology

Citations in the corpus

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, background): “For more information on lipid core micelles, please see Lukyanov and Torchilin (2004) and Torchilin (2007a).”
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy (2007, background): “Conclusion In the course of the past decade, the field of drug delivery has been revolutionized with the advent of nanotechnology, wherein biocompatible nanoparticles have been developed as inert systemic carriers for therapeutic compounds to target cells and tissues [33-38].”
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. (2007, background): “These strategies for improving and maximizing dissolution rate include micronisation to produce increased surface area for dissolution [1], the use of salt forms with enhanced dissolution profiles [2], solubilisation of drugs in co-solvents [3] and micellar solutions [4], complexation with cyclodext”
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic (2009, neutral): “Pure and Applied Chemistry 2008;80(8):1703–18.”
Fabrication, characterization, and cytotoxicity evaluation of cranberry procyanidins-zein nanoparticles (2012, background): “Nanoparticles are particularly useful for cancer chemoprevention due to their enhanced permeability and retention (EPR) effect, which describes the properties of nanoparticles to preferably accumulate on tumor tissues over normal tissues (Torchilin, 2007).”
Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant (2013, background): “Like some liposomes, micelles reduce the risk of embolization that occurs with administration of hydrophobic drugs by stabilizing the drug and preventing aggregation of drug complexes in the blood [25,26].”